Paper28087488
Cathepsin K-targeted sub-micron particles for regenerative repair of vascular elastic matrix.
Jennewine B and 2 others. Acta Biomater, 2017. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Cathepsin K-targeted sub-micron particles for regenerative repair of vascular elastic matrix. Papers, record 28087488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28087488
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cathepsin K | Major topic |
| Doxycycline | Major topic |
| Elastin | Major topic |
| Nanocapsules | Major topic |
| Regeneration | Major topic |
| Animals | |
| Cells, Cultured | |
| Muscle, Smooth, Vascular | |
| Myocytes, Smooth Muscle | |
| Particle Size | |
| Rats | |
| Rats, Sprague-Dawley |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R56 HL132856 | NHLBI NIH HHS | United States | R56HL132856 | PubMed and NIH | NIH RePORTER |
| S10 OD018205 | NIH HHS | United States | S10OD018205 | PubMed and NIH | NIH RePORTER |
| S10 RR031536 | NCRR NIH HHS | United States | S10RR031536 | PubMed and NIH | NIH RePORTER |
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9568639 | Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis. | Clin Exp Metastasis | 1998 | https://conductscience.org/library/papers/9568639 | PubMed |
| 2 | 21341992 | Elastogenic inductability of smooth muscle cells from a rat model of late stage abdominal aortic aneurysms. | Tissue Eng Part A | 2011 | https://conductscience.org/library/papers/21341992 | PubMed |
| 3 | 18491978 | Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles. | Expert Opin Drug Deliv | 2008 | https://conductscience.org/library/papers/18491978 | PubMed |
| 4 | 10701459 | Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects. | Biomaterials | 2000 | https://conductscience.org/library/papers/10701459 | PubMed |
| 5 | 16572291 | Localized administration of doxycycline suppresses aortic dilatation in an experimental mouse model of abdominal aortic aneurysm. | Ann Vasc Surg | 2006 | https://conductscience.org/library/papers/16572291 | PubMed |
| 6 | 8823004 | Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty. | Circulation | 1996 | https://conductscience.org/library/papers/8823004 | PubMed |
| 7 | 12096249 | Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. | J Vasc Surg | 2002 | https://conductscience.org/library/papers/12096249 | PubMed |
| 8 | 14681644 | Mechanism of inhibition of matrix metalloproteinase-2 expression by doxycycline in human aortic smooth muscle cells. | J Vasc Surg | 2003 | https://conductscience.org/library/papers/14681644 | PubMed |
| 9 | 2144219 | Elastase-induced experimental aneurysms in rats. | Circulation | 1990 | https://conductscience.org/library/papers/2144219 | PubMed |
| 10 | 9763536 | Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. | Arterioscler Thromb Vasc Biol | 1998 | https://conductscience.org/library/papers/9763536 | PubMed |
| 11 | 8637112 | Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. | J Vasc Surg | 1996 | https://conductscience.org/library/papers/8637112 | PubMed |
| 12 | 6158890 | A simple, rapid, and sensitive DNA assay procedure. | Anal Biochem | 1980 | https://conductscience.org/library/papers/6158890 | PubMed |
| 13 | 22562303 | Tumor necrosis factor alpha stimulates cathepsin K and V activity via juxtacrine monocyte-endothelial cell signaling and JNK activation. | Mol Cell Biochem | 2012 | https://conductscience.org/library/papers/22562303 | PubMed |
| 14 | 16651635 | Doxycycline alters vascular smooth muscle cell adhesion, migration, and reorganization of fibrillar collagen matrices. | Am J Pathol | 2006 | https://conductscience.org/library/papers/16651635 | PubMed |
| 15 | 11101159 | Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation. | Biomaterials | 2001 | https://conductscience.org/library/papers/11101159 | PubMed |
| 16 | 8548422 | Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. | Arterioscler Thromb Vasc Biol | 1996 | https://conductscience.org/library/papers/8548422 | PubMed |
| 17 | 19435455 | Current advances in research and clinical applications of PLGA-based nanotechnology. | Expert Rev Mol Diagn | 2009 | https://conductscience.org/library/papers/19435455 | PubMed |
| 18 | 23376127 | Multifunctional nanoparticles for doxycycline delivery towards localized elastic matrix stabilization and regenerative repair. | Acta Biomater | 2013 | https://conductscience.org/library/papers/23376127 | PubMed |
| 19 | 15264885 | Synthesis and characterization of dextran-peptide-methotrexate conjugates for tumor targeting via mediation by matrix metalloproteinase II and matrix metalloproteinase IX. | Bioconjug Chem | 2004 | https://conductscience.org/library/papers/15264885 | PubMed |
| 20 | 6113236 | Control of elastin metabolism by elastin ligands. Reciprocal effects on lysyl oxidase activity. | J Biol Chem | 1981 | https://conductscience.org/library/papers/6113236 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39429209 | Enhancing Exosomal Delivery to Abdominal Aortic Aneurysms using Magnetically Responsive Chemotactic Nanomotors for Elastic Matrix Regenerative Repair. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/39429209 | PubMed |
| 37093652 | Surface-Functionalized Stem Cell-Derived Extracellular Vesicles for Vascular Elastic Matrix Regenerative Repair. | Mol Pharm | 2023 | https://conductscience.org/library/papers/37093652 | PubMed |
| 35711380 | Applications of Extracellular Vesicles in Abdominal Aortic Aneurysm. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/35711380 | PubMed |
| 33799932 | Nanomaterials as Novel Cardiovascular Theranostics. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/33799932 | PubMed |
| 32504690 | Assessing the targeting and fate of cathepsin k antibody-modified nanoparticles in a rat abdominal aortic aneurysm model. | Acta Biomater | 2020 | https://conductscience.org/library/papers/32504690 | PubMed |
| 30061830 | Nanotherapeutics to Modulate the Compromised Micro-Environment for Lung Cancers and Chronic Obstructive Pulmonary Disease. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/30061830 | PubMed |
| 29559389 | Matrix remodeling in chronic lung diseases. | Matrix Biol | 2018 | https://conductscience.org/library/papers/29559389 | PubMed |
| 28875468 | Multifunctional, JNK-inhibiting nanotherapeutics for augmented elastic matrix regenerative repair in aortic aneurysms. | Drug Deliv Transl Res | 2018 | https://conductscience.org/library/papers/28875468 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTSK | 1513 | PubTator's text mining | https://conductscience.org/library/genes/1513 | NCBI Gene |
| ELN | 2006 | PubTator's text mining | https://conductscience.org/library/genes/2006 | NCBI Gene |
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| MMP9 | 4318 | PubTator's text mining | https://conductscience.org/library/genes/4318 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28087488
GET https://conductscience.org/api/papers/v1/28087488/references?page=2